Amanote Research

Amanote Research

    RegisterSign In

PCN107 Potential Benefits of Introducing a Companion Diagnostic in Advanced Non-Small Cell Lung Cancer

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1208
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

November 1, 2011

Authors
R. ZaimJ. GaultneyW. RedekopC. Uyl-de Groot
Publisher

Elsevier BV


Related search

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Developments in the Management of Advanced Non Small Cell Lung Cancer

Journal of Cancer Therapy
2013English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Anemia and Systemic Inflammation in Advanced Non-Small Cell Lung Cancer

Solunum
2013English

Potential Clinical Application of lncRNAs in Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy